Alzheimer's Disease - Event guide: 2nd Neuroscience Innovation Partnering & Licensing Summit
View as a Web Page
News Medical
 
  Alzheimer's Disease Alzheimer's Disease logo  
  The latest Alzheimer's disease news from News Medical  
 

A Spotlight on Neurological BiomarkersA Spotlight on Neurological Biomarkers

Neurological diseases remain some of the most complex and urgent challenges in human health—demanding precision tools and the courage to ask difficult questions.

Explore this resource hub to discover the scientists driving progress, fresh insights into disease mechanisms, and how proteomics is illuminating the path from understanding to real-world impact.

Explore the resource hub
 
 
    Event guide: 2nd Neuroscience Innovation Partnering & Licensing SummitEvent guide: 2nd Neuroscience Innovation Partnering & Licensing Summit
 
The 2nd Neuroscience Innovation Partnering & Licensing Summit is built to accelerate deal-making in neuroscience.
 
Get the Guide
 
 
   Scientists uncover nanoplastics in brain tissue and question their role in neurological diseaseScientists uncover nanoplastics in brain tissue and question their role in neurological disease
 
Emerging evidence suggests nanoplastics accumulate in human tissues including the brain and may contribute to neuroinflammation and neurodegenerative disease pathways. However, causality, exposure routes, and long-term health effects remain uncertain and require coordinated research.
 
 Does Ginkgo biloba help dementia? New review examines the evidence
 
Does Ginkgo biloba help dementia? New review examines the evidenceA major Cochrane review examines whether a widely used herbal supplement truly supports cognitive function, revealing modest dementia benefits but limited evidence for prevention or early impairment.
 
 
 Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof
 
Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proofThis review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, inflammatory, mitochondrial, and proteostasis pathways. Evidence from mechanistic, preclinical, and early clinical studies suggests potential neuroprotective effects, but definitive disease-modifying benefit remains unproven.
 
 
 IFN-γ identified as a powerful blood biomarker for Alzheimer’s
 
IFN-γ identified as a powerful blood biomarker for Alzheimer’sThis study identifies IFN-γ as a crucial blood-based biomarker for Alzheimer's, revealing its role in microglial inflammation and genetic risk interactions.
 
 
 Human 3D Model Shows How the Gut Drives Neurodegeneration
 
Human 3D Model Shows How the Gut Drives NeurodegenerationResearch on a 3D microfluidic model highlights gut-brain interactions, offering new insights into inflammatory processes linked to neurodegenerative diseases.
 
 
 A simple handgrip test reveals how strong your working memory may be
 
A simple handgrip test reveals how strong your working memory may beGrip strength correlates with working memory performance and prefrontal activation, highlighting its potential as a cognitive health marker in older adults.
 
 
 Air pollution linked to higher risk of developing Alzheimer's disease
 
Air pollution linked to higher risk of developing Alzheimer's diseasePeople with greater exposure to air pollution face a higher risk of developing Alzheimer's disease, according to a new study by Yanling Deng of Emory University, U.S.A., and colleagues, published February 17th in the open-access journal PLOS Medicine.
 
 
 Exercise and protein drinks improve function in people with dementia
 
Exercise and protein drinks improve function in people with dementiaA simple combination of daily physical exercise and protein-rich nutritional drinks appears to offer significant health benefits for people with dementia.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026